Authors: Tuldra, A Fumaz, CR Ferrer, MJ Bayes, R Arno, A Balague, M Bonjoch, A Jou, A Negredo, E Paredes, R Ruiz, L Romeu, J Sirera, G Tural, C Burger, D Clotet, B

Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228

Authors: Paredes, R Puig, T Arno, A Negredo, E Balague, M Bonjoch, A Jou, A Tuldra, A Tural, C Sirera, G Veny, A Romeu, J Ruiz, L Clotet, B

Citation: R. Paredes et al., High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response, J ACQ IMM D, 22(2), 1999, pp. 132-138

Authors: Negredo, E Paredes, R Bonjoch, A Tuldra, A Fumaz, CR Gel, S Garces, B Johnston, S Arno, A Balague, M Jou, A Tural, C Sirera, G Romeu, J Cruz, L Francia, E Domingo, P Arrizabalaga, J Ruiz, I Arribas, JR Ruiz, L Clotet, B

Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28

Authors: Blanco, J Cabrera, C Jou, A Ruiz, L Clotet, B Este, JA

Citation: J. Blanco et al., Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy, AIDS, 13(5), 1999, pp. 547-555

Authors: Arno, A Ruiz, L Juan, M Jou, A Balague, M Zayat, MK Marfil, S Martinez-Picado, J Martinez, MA Romeu, J Pujol-Borrell, R Lane, C Clotet, B

Citation: A. Arno et al., Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <= 250/mu L CD4 T cells and undetectable plasma virus load, J INFEC DIS, 180(1), 1999, pp. 56-60